Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,247 | 50 | 69.8% |
| Food and Beverage | $19,508 | 1,203 | 14.9% |
| Consulting Fee | $13,650 | 9 | 10.4% |
| Travel and Lodging | $5,940 | 41 | 4.5% |
| Education | $300.23 | 6 | 0.2% |
| Gift | $82.00 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $42,563 | 163 | $0 (2024) |
| GENZYME CORPORATION | $39,761 | 54 | $0 (2022) |
| Genentech USA, Inc. | $33,362 | 50 | $0 (2024) |
| ABBVIE INC. | $1,493 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,308 | 113 | $0 (2024) |
| Biogen, Inc. | $1,141 | 55 | $0 (2024) |
| Allergan, Inc. | $821.68 | 69 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $656.64 | 68 | $0 (2021) |
| UCB, Inc. | $608.72 | 41 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $603.21 | 49 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,975 | 126 | ABBVIE INC. ($413.66) |
| 2023 | $2,375 | 147 | ABBVIE INC. ($433.31) |
| 2022 | $2,382 | 166 | ABBVIE INC. ($398.54) |
| 2021 | $8,417 | 185 | Teva Pharmaceuticals USA, Inc. ($6,497) |
| 2020 | $9,458 | 100 | Teva Pharmaceuticals USA, Inc. ($8,347) |
| 2019 | $23,285 | 173 | Genentech USA, Inc. ($11,399) |
| 2018 | $35,087 | 200 | Genentech USA, Inc. ($14,057) |
| 2017 | $47,747 | 217 | GENZYME CORPORATION ($27,681) |
All Payment Transactions
1,314 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: PAIN | ||||||
| 11/20/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $15.61 | General |
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Neurology | ||||||
| 11/15/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: PAIN | ||||||
| 10/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| 10/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 914 | 1,150 | $186,973 | $132,149 |
| 2022 | 10 | 764 | 968 | $168,259 | $124,255 |
| 2021 | 12 | 804 | 1,070 | $184,340 | $135,463 |
| 2020 | 11 | 751 | 950 | $149,092 | $106,940 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 510 | $73,395 | $50,073 | 68.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 133 | 133 | $24,685 | $17,970 | 72.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 99 | 99 | $25,727 | $17,796 | 69.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 52 | 53 | $12,554 | $9,523 | 75.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 64 | $12,458 | $9,335 | 74.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 45 | $9,142 | $6,583 | 72.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 76 | $7,702 | $5,593 | 72.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 41 | 52 | $5,889 | $4,192 | 71.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $2,837 | $2,224 | 78.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 22 | $3,050 | $2,136 | 70.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $2,806 | $2,111 | 75.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 17 | 17 | $2,745 | $1,981 | 72.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 24 | $2,070 | $1,623 | 78.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 21 | 21 | $1,915 | $1,008 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 276 | 458 | $66,838 | $47,312 | 70.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 114 | 114 | $28,278 | $21,687 | 76.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 78 | 80 | $18,871 | $15,101 | 80.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $19,720 | $14,238 | 72.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 46 | $10,239 | $7,965 | 77.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 44 | $9,185 | $6,591 | 71.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 43 | $4,420 | $3,239 | 73.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 23 | 36 | $4,279 | $3,212 | 75.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $2,822 | $2,106 | 74.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 14 | 14 | $2,246 | $1,809 | 80.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 16 | $1,361 | $993.85 | 73.0% |
About Dr. Stuart Fox, M.D
Dr. Stuart Fox, M.D is a Neurology healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063413102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Fox, M.D has received a total of $130,727 in payments from pharmaceutical and medical device companies, with $1,975 received in 2024. These payments were reported across 1,314 transactions from 91 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,247).
As a Medicare-enrolled provider, Fox has provided services to 3,233 Medicare beneficiaries, totaling 4,138 services with total Medicare billing of $498,807. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Morristown, NJ
- Active Since 08/10/2005
- Last Updated 06/19/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063413102
Products in Payments
- AUBAGIO (Drug) $39,680
- OCREVUS (Biological) $25,491
- AJOVY (Biological) $14,860
- COPAXONE (Drug) $12,401
- AJOVY (Drug) $10,057
- Non-Covered Product (Drug) $7,776
- BOTOX (Biological) $1,036
- KESIMPTA (Drug) $787.20
- TYSABRI (Biological) $724.63
- APTIOM (Drug) $586.40
- TROKENDI XR (Drug) $510.20
- ZEPOSIA (Drug) $425.56
- AUSTEDO (Drug) $408.13
- Hizentra (Biological) $380.20
- UBRELVY (Drug) $347.31
- NURTEC ODT (Drug) $325.79
- QULIPTA (Drug) $287.54
- Briviact (Drug) $285.65
- GILENYA (Drug) $275.43
- LYRICA (Drug) $248.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Morristown
Mark Diamond, Md, MD
Neurology — Payments: $115,541
Ruchir Shah, M.d, M.D
Neurology — Payments: $19,267
Richard Rosenberg, M.d, M.D
Neurology — Payments: $17,671
Mr. Mathew Alias, D.o, D.O
Neurology — Payments: $15,812
Tatyana Marx
Neurology — Payments: $9,992
Anna Iones
Neurology — Payments: $4,432